Novel vaccine may hold key to prevent or reduce the impact of Alzheimer’s disease Dr. Kamal Kant Kohli9 Aug 2023 8:00 PM ISTA novel vaccine that targets inflamed brain cells associated with Alzheimer’s disease may hold the key to potentially preventing or modifying the...
Serum Institute Of India Gets CDSCO Panel Nod To study Dengue Tetravalent Vaccine Dr. Divya Colin1 Aug 2023 6:00 PM ISTNew Delhi: Vaccine major Serum Institute of India has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Biological E Gets CDSCO panel Nod for Post-marketing Surveillance study of Hepatitis B Vaccine Dr. Divya Colin30 July 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has given its nod to the vaccine...
Maternal vaccine promising for prevention of Group B Streptococcus infection in infants: NEJM Dr. Kamal Kant Kohli24 July 2023 8:00 PM ISTUSA: A recent study published in The New England Journal of Medicine has revealed the potential of a maternally administered vaccine for infant group...
Early MMR Vaccination is not linked to Reduction in Hospitalizations for Non-Targeted Infections in Infants: BMJ study Aditi21 July 2023 8:15 AM ISTA recent study conducted in Denmark, published in BMJ entitled "Measles, mumps, and rubella vaccine at age six months and hospitalization for...
WHO prequalifies SII Multivalent meningococcal meningitis vaccine Ruchika Sharma13 July 2023 2:10 PM ISTMenFive is approved by WHO for use in individuals 1 through 85 years of age and will initially be available for use in reactive vaccine campaigns for...
GSK gets CDSCO panel Nod for Phase III Extension safety follow-up study for trial of RSVPreF3 vaccine Dr. Divya Colin12 July 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
GSK RSV shot Arexvy approved in Britain for adults aged 60 years and older Ruchika Sharma10 July 2023 3:30 PM ISTBritain: Britain's health regulator approved GSK's vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and...
Novavax Nuvaxovid gets full marketing authorization in EU for COVID prevention Ruchika Sharma9 July 2023 10:00 AM ISTGaithersburg: Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, has been granted full Marketing...
FDA grants fast-track designation to new gonorrhea vaccine Dr. Kamal Kant Kohli8 July 2023 9:45 AM ISTUSA: The US Food and Drug Administration (FDA) has granted Fast Track designation to the investigational gonorrhoea vaccine developed by drugmaker...
Moderna announces global regulatory submissions for respiratory syncytial virus vaccine Ruchika Sharma6 July 2023 12:30 PM ISTmRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Moderna submits regulatory application to EMA for updated COVID vaccine Ruchika Sharma3 July 2023 4:28 PM ISTCambridge: Moderna, Inc., a biotechnology company, today announced that it has submitted a regulatory application to the European Medicines Agency...
